Detalhe da pesquisa
1.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
N Engl J Med
; 389(20): 1862-1876, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966285
2.
Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model).
Alzheimers Dement
; 19(6): 2287-2297, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454709
3.
Concern about Tominersen in Patients with Huntington's Disease. Reply.
N Engl J Med
; 390(11): 1059, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478006
4.
Gantenerumab in Early Alzheimer's Disease. Reply.
N Engl J Med
; 390(9): 867, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416440
5.
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
N Engl J Med
; 370(4): 311-21, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450890
6.
A phase 3 trial of semagacestat for treatment of Alzheimer's disease.
N Engl J Med
; 369(4): 341-50, 2013 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23883379
7.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
BMC Neurol
; 16: 89, 2016 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276999
8.
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
CNS Spectr
; 21(6): 450-459, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26471212
9.
Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.
Alzheimers Dement
; 12(1): 75-84, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079412
10.
The Dementia and Disability Project in Thai Elderly: rational, design, methodology and early results.
BMC Neurol
; 13: 3, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23305293
11.
Effectiveness of antidementia drugs in delaying Alzheimer's disease progression.
Alzheimers Dement
; 9(3): 338-45, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23102979
12.
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
N Engl J Med
; 370(15): 1460, 2014 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24716687
13.
Greater precision when measuring dementia severity: establishing item parameters for the Clinical Dementia Rating Scale.
Dement Geriatr Cogn Disord
; 34(2): 128-34, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006935
14.
Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine.
Dement Geriatr Cogn Disord
; 33(2-3): 164-73, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22572767
15.
Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies.
Neurodegener Dis
; 10(1-4): 170-4, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22327239
16.
Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.
Alzheimers Dement
; 8(4): 288-94, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22465173
17.
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease.
Alzheimers Res Ther
; 14(1): 178, 2022 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447240
18.
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials.
JAMA Neurol
; 79(11): 1113-1121, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121669
19.
Semagacestat for treatment of Alzheimer's disease.
N Engl J Med
; 369(17): 1661, 2013 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24152267
20.
Dementia staging across three different methods.
Dement Geriatr Cogn Disord
; 31(5): 328-33, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21555887